A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer
Clinical trial NCT00934856 · COMPLETED
Trial details
- NCT number
- NCT00934856
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-10-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.